Masimo Corporation

MASI Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
News

Chart provided by TradingView

Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of MASI by members of U.S. Congress

Politician Type Traded
Kevin Hern House / R Sale $15,001 - $50,000 Sep 26, 2025
Kevin Hern House / R Sale $50,001 - $100,000 Dec 19, 2022
Tommy Tuberville Senate / R Sale (Full) $1,001 - $15,000 Oct 05, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 May 23, 2022
Ro Khanna House / D Sale $1,001 - $15,000 N/A
Tommy Tuberville Senate / R Purchase $1,001 - $15,000 Mar 30, 2022
Ro Khanna House / D Sale $1,001 - $15,000 Feb 17, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 Jan 21, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 Nov 08, 2021
Kevin Hern House / R Purchase $15,001 - $50,000 Jun 25, 2021
Kevin Hern House / R Purchase $100,001 - $250,000 Jun 25, 2021
Thom Tillis Senate / R Sale (Full) $1,001 - $15,000 Feb 13, 2015
MASI Stock Insider Trading Activity Follow @QuiverQuant for major insider updates
Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
MASI Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
MASI Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in MASI holdings by institutional investors

Insider Trading

Quarterly net insider trading by MASI's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

  • $50,000 Oct 17, 2025 Issue: Health Issues Tariff (miscellaneous tariff bills)
  • $110,000 Jul 17, 2025 Issue: Health Issues Tariff (miscellaneous tariff bills)
  • $100,000 Apr 21, 2025 Issue: Health Issues Tariff (miscellaneous tariff bills)
  • $80,000 Jan 16, 2025 Issue: Health Issues Copyright/Patent/Trademark Tariff (miscellaneous tariff bills)
  • $140,000 Oct 21, 2024 Issue: Copyright/Patent/Trademark Health Issues
  • $120,000 Jul 19, 2024 Issue: Health Issues
  • $190,000 Apr 24, 2024 Issue: Copyright/Patent/Trademark Health Issues
  • $100,000 Jan 22, 2024 Issue: Copyright/Patent/Trademark Health Issues
  • $130,000 Oct 19, 2023 Issue: Copyright/Patent/Trademark Health Issues
  • $100,000 Jul 20, 2023 Issue: Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues
  • $200,000 Jan 20, 2023 Issue: Labor Issues/Antitrust/Workplace Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues
  • $100,000 Oct 19, 2022 Issue: Copyright/Patent/Trademark Health Issues
  • $60,000 Jul 19, 2022 Issue: Immigration Taxation/Internal Revenue Code Copyright/Patent/Trademark Consumer Issues/Safety/Products Health Issues
  • $80,000 Apr 19, 2022 Issue: Immigration Taxation/Internal Revenue Code Copyright/Patent/Trademark Consumer Issues/Safety/Products Health Issues
  • $70,000 Jan 20, 2022 Issue: None
  • $100,000 Oct 20, 2021 Issue: None
  • $50,000 Jul 19, 2021 Issue: None
  • $60,000 Apr 20, 2021 Issue: None
  • $50,000 Jan 20, 2021 Issue: None
  • $80,000 Oct 19, 2020 Issue: HEALTH ISSUES
  • $90,000 Jul 20, 2020 Issue: None
  • $130,000 Apr 16, 2020 Issue: HEALTH ISSUES
  • $70,000 Jan 21, 2020 Issue: HEALTH ISSUES
  • $80,000 Oct 21, 2019 Issue: Health Issues
  • $60,000 Jul 22, 2019 Issue: Health Issues
  • $20,000 Apr 01, 2019 Issue: Labor Issues/Antitrust/Workplace
  • $20,000 Jan 03, 2019 Issue: Labor Issues/Antitrust/Workplace
  • $20,000 Oct 01, 2018 Issue: Labor Issues/Antitrust/Workplace
  • $20,000 Jul 02, 2018 Issue: Labor Issues/Antitrust/Workplace
  • $20,000 Apr 04, 2018 Issue: Labor Issues/Antitrust/Workplace
  • $20,000 Jan 03, 2018 Issue: Labor Issues/Antitrust/Workplace
  • $20,000 Oct 03, 2017 Issue: Labor Issues/Antitrust/Workplace
  • $20,000 Jul 05, 2017 Issue: Labor Issues/Antitrust/Workplace
  • $20,000 Apr 03, 2017 Issue: Labor Issues/Antitrust/Workplace
  • $20,000 Jan 04, 2017 Issue: Labor Issues/Antitrust/Workplace
  • $20,000 Oct 05, 2016 Issue: Labor Issues/Antitrust/Workplace
  • $20,000 Jul 07, 2016 Issue: Labor Issues/Antitrust/Workplace
  • $20,000 Apr 01, 2016 Issue: Labor Issues/Antitrust/Workplace
  • $20,000 Jan 06, 2016 Issue: Immigration Labor Issues/Antitrust/Workplace
  • $20,000 Oct 01, 2015 Issue: Labor Issues/Antitrust/Workplace
  • $20,000 Jul 07, 2015 Issue: Labor Issues/Antitrust/Workplace
  • $20,000 Apr 03, 2015 Issue: Labor Issues/Antitrust/Workplace
  • $20,000 Jan 05, 2015 Issue: Labor Issues/Antitrust/Workplace
  • $20,000 Oct 01, 2014 Issue: Labor Issues/Antitrust/Workplace
  • $20,000 Jul 02, 2014 Issue: Labor Issues/Antitrust/Workplace
  • $20,000 Apr 02, 2014 Issue: Labor Issues/Antitrust/Workplace
  • $20,000 Jan 02, 2014 Issue: Labor Issues/Antitrust/Workplace
  • $30,000 Oct 01, 2013 Issue: Health Issues Labor Issues/Antitrust/Workplace
  • $30,000 Jul 01, 2013 Issue: Labor Issues/Antitrust/Workplace
  • $10,000 Jan 19, 2010 Issue: Taxation/Internal Revenue Code Health Issues
Corporate Lobbying

MASI Estimated quarterly lobbying spending

Revenue Breakdown

MASI Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
MASI Income Statement
MASI Balance Sheet
MASI Cash Flow
U.S. Patents

New MASI patent grants

  • Patent Title: Connector May. 09, 2023
  • Patent Title: Wearable temperature measurement device Mar. 07, 2023
  • Patent Title: Connector Feb. 28, 2023
  • Patent Title: Wearable temperature measurement device Jan. 03, 2023
  • Patent Title: Display screen or portion thereof with graphical user interface Dec. 27, 2022
  • Patent Title: Display screen or portion thereof with graphical user interface Dec. 27, 2022
  • Patent Title: Display screen or portion thereof with graphical user interface Dec. 20, 2022
  • Patent Title: Display screen or portion thereof with graphical user interface Dec. 06, 2022
  • Patent Title: Patient monitor Oct. 18, 2022
  • Patent Title: Blood pressure monitor Oct. 04, 2022
  • Patent Title: Dongle Jul. 12, 2022
  • Patent Title: Electrode pad May. 03, 2022
  • Patent Title: Display screen or portion thereof with graphical user interface May. 03, 2022
  • Patent Title: Display screen or portion thereof with graphical user interface May. 03, 2022
  • Patent Title: Display screen or portion thereof with graphical user interface Mar. 22, 2022
  • Patent Title: Display screen or portion thereof with graphical user interface Mar. 22, 2022
  • Patent Title: Display screen or portion thereof with graphical user interface Mar. 22, 2022
  • Patent Title: Display screen or portion thereof with graphical user interface Mar. 22, 2022
  • Patent Title: Patient monitor Oct. 12, 2021
  • Patent Title: Blood pressure device Oct. 12, 2021
  • Patent Title: Blood pressure monitor Oct. 12, 2021
  • Patent Title: Electrode pad Aug. 10, 2021
  • Patent Title: Display screen or portion thereof with graphical user interface Jul. 20, 2021
  • Patent Title: Holder for a blood pressure device Jun. 01, 2021
  • Patent Title: Holder for a patient monitor May. 11, 2021
  • Patent Title: Blood pressure device May. 11, 2021
  • Patent Title: Patient monitor Apr. 27, 2021
  • Patent Title: Display screen or portion thereof with graphical user interface Apr. 27, 2021
  • Patent Title: Display screen or portion thereof with a graphical user interface Apr. 27, 2021
  • Patent Title: Cap for a flow alarm device Apr. 20, 2021
  • Patent Title: Display screen or portion thereof with a graphical user interface Apr. 13, 2021
  • Patent Title: Wingnut for a flow alarm device Jan. 19, 2021
  • Patent Title: Connector Jan. 05, 2021
  • Patent Title: Card holder set Sep. 29, 2020
  • Patent Title: Connector Jul. 21, 2020
  • Patent Title: Flow alarm device housing Jun. 16, 2020
  • Patent Title: Display screen or portion thereof with a graphical user interface for physiological monitoring Jun. 09, 2020
  • Patent Title: Connector Apr. 07, 2020
  • Patent Title: Connector Oct. 22, 2019
  • Patent Title: Medical monitoring device Dec. 04, 2018
  • Patent Title: Medical monitoring device Dec. 04, 2018
  • Patent Title: Medical monitoring device Dec. 04, 2018
  • Patent Title: Medical monitoring device Dec. 04, 2018
  • Patent Title: Medical device Nov. 13, 2018
  • Patent Title: Medical monitoring device Jul. 03, 2018
  • Patent Title: Medical monitoring device Jul. 03, 2018
  • Patent Title: Display screen or portion thereof for graphical user interface for physiological monitoring Jun. 19, 2018
  • Patent Title: Wireless patient monitoring device May. 30, 2017
  • Patent Title: Pulse oximetry sensor May. 03, 2016
  • Patent Title: Medical proximity detection token Oct. 22, 2013
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to MASI from public contracts

MASI News

Recent insights relating to MASI

CNBC Recommendations

Recent picks made for MASI stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MASI

MASI Analyst Ratings

MASI Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
MASI Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $MASI stock a Buy, Sell, or Hold?

  • What is the price target for $MASI stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

MASI Top Shareholders
Shareholder
Shares Held
MASI Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $MASI stock?

  • Who owns the most shares of $MASI stock?

  • What funds own $MASI stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

MASI Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view MASI Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About MASI

Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.

  • Address Irvine, CA
  • Market Cap 7.4 billion
  • Employees 3,600
  • Industrial Classification Electromedical & Electrotherapeutic Apparatus
Back To Top